Papilio.Bio

Cervical cancer is the fourth most common cancer in women. HPV-associated Cervical cancer accounts for 95% of HPV-attributable cancers Papilio.Bio is developing a self-test for detecting HPV, designed for both men and women, to make prevention more accessible and reduce cases of cervical cancer by empowering individuals' control over their health.